Event Details

;

Amarin Corporation’s Fourth Quarter & Full Year 2024 Results

12 Mar 2025

Review Event

Investor Contact

For corporate governance, analyst coverage, stock information, secretarial matters and other investor-related queries, please use the contact form

About Amarin for Investors

Amarin is a leading cardiovascular health pharmaceutical company. As leaders, we apply science, research, passion and global knowledge to ensure we encompass our vision of stopping heart disease from being a leading cause of death. In order to achieve this vision, we take a strategic approach to management and financial responsibility.

Corporate Governance

Gain new insights into Amarin’s performance and corporate commitments.

Financial Information

Learn more about Amarin’s revenue, expenses, profit and loss, as well as a comprehensive overview of the company’s financial health.

Analyst Coverage

Find out which firms and analysts are covering Amarin.

Stock Information

View real-time stock prices and stock quotes.

About Amarin

A new paradigm in cardiovascular health management

Amarin Corporation is focused on a BOLD vision to stop cardiovascular disease from being a leading cause of death. Find out more about our vision and how we lead the way to better care for those with cardiovascular disease.

Science and Health

Passionate about cardiometabolic science and health

Learn more about the science underpinning our product and research & development efforts to advance innovation in cardiovascular disease.

News and Media

Press releases, news, updates and statements

From reports and reviews to partnerships and innovations, find out more about Amarin's latest news and stories as they stand in the press.

ALL-NP-00016 1/23